Naoto Okada

Factors Associated With Immune Checkpoint Inhibitor–Related Myocarditis

Yoshito Zamami, Takahiro Niimura, Naoto Okada et al. · JAMA Oncology · 2019 · 135 citations · Full text

Life Sciences, Cardiology, Immunology +17

Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study

Naoto Okada, Kenshi Takechi, Yoshihiro Matsudate et al. · Clinical Therapeutics · 2018 · 99 citations

Medicine, Immunology, Oncology +17

Risk factors of immune checkpoint inhibitor-related interstitial lung disease in patients with lung cancer: a single-institution retrospective study

Naoto Okada, Rie Matsuoka, Takumi Sakurada et al. · Scientific Reports · 2020 · 68 citations · Full text

Medicine, Immunology, Oncology +15

Identification of the Risk Factors Associated with Hypocalcemia Induced by Denosumab

Naoto Okada, Kazuyoshi Kawazoe, Kazuhiko Teraoka et al. · Biological and Pharmaceutical Bulletin · 2013 · 64 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Antitumor effect of novel anti‐podoplanin antibody NZ‐12 against malignant pleural mesothelioma in an orthotopic xenograft model

Shinji Abe, Mika K. Kaneko, Yuki Tsuchihashi et al. · Cancer Science · 2016 · 62 citations · Full text

Medicine, Oncology, Pharmacology +16